Salvadoran pharmaceutical manufacturing combines skilled workers, modern technology, and international exports. AI-generated image created for Our Life in El Salvador.
When people think about El Salvador’s exports, coffee, sugar, textiles, and manufactured goods often come to mind. Yet another Salvadoran industry has been quietly building a strong international reputation: pharmaceuticals.
Laboratorios VIJOSA has now been recognized as El Salvador’s leading exporter in the chemical-pharmaceutical sector for the 15th consecutive year. The recognition came through the 2026 Industrial Ranking prepared by the Salvadoran Association of Industrialists (ASI).
This is more than an award for one company. It is evidence that Salvadoran industry can produce sophisticated, highly regulated products that compete beyond our borders.
Fifteen Years at the Top
VIJOSA has held first place in pharmaceutical exports every year from 2012 through 2026. Remaining at the top for that long requires more than one successful product or a few favorable years.
It demands consistent quality, continued investment, trained employees, and the ability to respond to changing markets. Pharmaceutical manufacturing also carries a special responsibility. The products leaving a factory may eventually affect the health and well-being of thousands of people.
For that reason, trust is essential.
In addition to leading its own sector, VIJOSA placed among the top 10 companies in six of the seven general categories evaluated by ASI. These included industrial exports, business growth, local sales, exports within Central America, specialized international destinations, and the number of countries reached.
That broader performance shows a company that is not simply maintaining its position. It is continuing to grow and expand.
Salvadoran Medicine Reaching International Markets
Today, approximately 68% of VIJOSA’s production is exported. Its medicines reach more than 13 markets, including Guatemala, Honduras, Nicaragua, Costa Rica, Panama, Belize, the United States, the Dominican Republic, Aruba, Curaçao, Paraguay, and Ecuador.
This regional presence matters for El Salvador.
Every Salvadoran product sold abroad carries the name of our country with it. When those products meet international standards, they help build confidence in the nation’s entire manufacturing sector.
One successful exporter can also open doors for others. Buyers who develop confidence in Salvadoran pharmaceuticals may become more willing to consider food products, medical supplies, technology, and other goods made here.
Exports are not only about earning revenue. They are also about building a national reputation.
More Than 700 Pharmaceutical Products
VIJOSA’s portfolio now includes more than 700 medicines in different forms and presentations. These products are manufactured across 14 automated production plants.
The scale of that operation challenges old ideas about the limits of Salvadoran manufacturing. El Salvador is a small country, but size does not prevent it from developing modern and technically advanced industries.
According to the company, its production follows demanding international standards, including PIC/S Annex 1 and guidelines contained in World Health Organization Report 53. These standards address areas such as pharmaceutical quality, contamination control, manufacturing procedures, and patient safety.
Meeting such requirements takes specialized equipment and careful oversight. It also depends on chemists, pharmacists, engineers, technicians, quality-control personnel, and many other trained employees.
Behind every box of medicine is a much larger network of Salvadoran knowledge and labor.
Growth That Exceeds the Regional Pace
VIJOSA’s recent growth also stands out. Between 2024 and 2025, the company reportedly reached 106% growth by the measurement used in the industrial ranking. That compares with 104% for El Salvador’s pharmaceutical industry and 102% across Central America.
Numbers like these suggest that VIJOSA is advancing slightly faster than both the domestic industry and the broader regional market.
However, growth in this sector cannot be measured only by increased production. A pharmaceutical company must expand without weakening its quality controls. That balance becomes more difficult as production lines multiply and new markets are added.
VIJOSA’s continued recognition indicates that long-term planning and investment have helped the company manage that challenge.
Technology Is Changing the Factory
Another important part of the story is VIJOSA’s use of artificial intelligence and other advanced technologies.
The company is integrating AI into its operations to improve processes, support continuous improvement, and optimize production. This does not necessarily mean replacing the people who make the company successful. Used responsibly, technology can help employees identify problems sooner, reduce waste, maintain consistency, and make better decisions.
In pharmaceutical production, even a small improvement can matter. Greater precision may result in safer products, fewer manufacturing errors, and more efficient use of materials.
We often discuss artificial intelligence in relation to computers, tourism platforms, or customer service. VIJOSA demonstrates that its influence is also reaching the factory floor.
The question is no longer whether Salvadoran companies will use these technologies. The more important question is how they will use them to increase productivity while continuing to invest in people.
The Workers Behind the Recognition
Mónica Saca, VIJOSA’s corporate director, credited the achievement to the commitment of the company’s employees. She described quality, excellence, and teamwork as central parts of what the company calls its “VIJOSA DNA.”
That acknowledgment is important.
Industrial success is sometimes described through buildings, machinery, and export figures. Yet none of those things accomplish anything without people. Someone must operate the equipment, examine the ingredients, inspect the finished products, maintain the machinery, prepare the documentation, and coordinate shipments.
VIJOSA reports employing more than 1,000 people. Those jobs support families and help build technical experience within El Salvador’s workforce.
They also create opportunities for young Salvadorans who may wish to pursue careers in science, engineering, medicine, logistics, or industrial technology without leaving the country.
What This Means for El Salvador
This recognition comes at a time when El Salvador is working to attract new investment and strengthen its position in regional trade.
Pharmaceutical manufacturing can play a valuable role in that process. It produces higher-value goods, depends on skilled labor, and requires modern infrastructure. It also connects several areas of the economy, including transportation, packaging, printing, research, technology, and professional services.
VIJOSA’s success shows that the foundation already exists.
The next step is to build upon it. That means strengthening technical education, supporting scientific research, improving logistics, and creating conditions that allow Salvadoran companies to enter additional markets.
It also means encouraging more businesses to think beyond the domestic market.
A Salvadoran Success Worth Recognizing
Fifteen consecutive years as the country’s leading pharmaceutical exporter is not an achievement that happened overnight. It represents decades of accumulated experience and thousands of daily decisions about quality, technology, employees, and investment.
VIJOSA has operated for more than 50 years. Its latest recognition demonstrates how a long-established Salvadoran company can continue evolving without losing sight of its original purpose.
There is something encouraging in seeing medicine manufactured in Santa Tecla reaching pharmacies and patients across Central America, the Caribbean, South America, and the United States.
It reminds us that “Made in El Salvador” can represent more than tradition. It can also represent science, precision, innovation, and international quality.
VIJOSA’s anniversary at the top of the export ranking belongs first to the company and its employees. At the same time, it gives all Salvadorans another reason to take pride in what this small country can produce and share with the world.
Sources: Reporting by Diario El Salvador, supplemented by information from Laboratorios VIJOSA and coverage of the 2026 ASI Industrial Ranking.
Leave a Reply